Cas Lek Cesk. 2020 Winter;159(7-8):275-280.
Many different substances with varying mechanisms of effects have been tested both in animal experiments, as well as verified in clinical studies as potential radioprotectors and mitigators of radiation damage. Among them, especially cytokines and hematopoietic growth factors have been used also for treatment of radiation accident victims. Two granulocyte colony-stimulating factor-based radiation countermeasures have been approved already for the treatment of the acute radiation syndrome. Nevertheless, a wide spectrum of other substances comprising, e.g., various immunomodulators, prostaglandins, inhibitors of prostaglandin synthesis, agonists of adenosine receptors, herbal extracts, flavonoids, vitamins, and others, has also been studied. These agents with various mechanisms of their influences on an organism are often effective, relatively non-toxic, and cheap. This review concentrates predominantly on the results of experiments which show the potential of untraditional or new radiation countermeasures to become a part of therapeutic procedures applicable in patients with the acute radiation syndrome.
许多具有不同作用机制的物质已经在动物实验中进行了测试,并在临床研究中验证了它们作为潜在的辐射防护剂和辐射损伤缓解剂的作用。其中,细胞因子和造血生长因子尤其被用于治疗辐射事故受害者。已经有两种基于粒细胞集落刺激因子的辐射防护措施被批准用于治疗急性辐射综合征。然而,还研究了其他广泛的物质,包括各种免疫调节剂、前列腺素、前列腺素合成抑制剂、腺嘌呤受体激动剂、草药提取物、类黄酮、维生素等。这些具有不同作用机制的药物通常有效、相对无毒且廉价。这篇综述主要集中在实验结果上,这些结果表明,非传统或新型辐射防护措施有可能成为适用于急性辐射综合征患者的治疗程序的一部分。